Back
Standard BioTools 10K Form
Sell
37
LAB
Standard BioTools
Last Price:
$1.15
Seasonality Move:
-7.18%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive LAB News And Ratings
See the #1 stock for the next 7 days that we like better than LAB
LAB Financial Statistics
Sales & Book Value
| Annual Sales: | $174.4M |
|---|---|
| Cash Flow: | $-17.4M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.25 |
| Price / Book: | 0.92 |
Profitability
| EPS (TTM): | -0.55000 |
|---|---|
| Net Income (TTM): | $-138.9M |
| Gross Margin: | $84.3M |
| Return on Equity: | -36.54% |
| Return on Assets: | -22.38% |
Standard BioTools Earnings Forecast
Key Standard BioTools Financial Ratios
-
The Gross Profit Margin over the past 19 years for LAB is 48.31%.
-
The Selling, General & Administrative Expenses for LAB have been equal to 89.78% of Gross Profit Margin.
-
The Research & Development expenses have been 35.78% of Revenue.
-
The Net Earning history of LAB is -79.62% of Total Revenues.
-
Per Share Earnings over the last 19 years have been positive in 11 years.
Standard BioTools Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Life Sciences Tools & Services |
| Sector: | Health Care |
| Current Symbol: | LAB |
| Website: | standardbio.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 5.7 |
| Quick Ratio: | 4.95 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 39 |
LAB Technical Analysis vs Fundamental Analysis
Sell
37
Standard BioTools (LAB)
is a Sell
Is Standard BioTools a Buy or a Sell?
-
Standard BioTools stock is rated a SellThe current Standard BioTools [LAB] share price is $1.14. The Score for LAB is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.